Coverage
-
February 17, 2015
Syringe maker Retractable Technologies Inc. has claimed it deserves $5.65 million in prejudgment interest from rival Becton Dickinson & Co. on top of the $340 million it won in a false advertising and antitrust suit, saying Becton's persistent stall tactics justify the award.
11 other articles on this case.
View all »